These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34428364)

  • 1. Cytokine storm syndrome in SARS-CoV-2: a review.
    Wahid B; Rani N; Idrees M
    Z Naturforsch C J Biosci; 2022 Jan; 77(1-2):65-69. PubMed ID: 34428364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted.
    Verma HK; Bhaskar L
    World J Gastroenterol; 2021 Dec; 27(45):7855-7858. PubMed ID: 34963747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and COVID-19: friends or foes?
    Rokni M; Hamblin MR; Rezaei N
    Hum Vaccin Immunother; 2020 Oct; 16(10):2363-2365. PubMed ID: 32841579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
    Chong ZZ; Souayah N
    Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges.
    Ali FEM; Mohammedsaleh ZM; Ali MM; Ghogar OM
    World J Gastroenterol; 2021 Apr; 27(15):1531-1552. PubMed ID: 33958841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications.
    Machado C; González-Quevedo A
    MEDICC Rev; 2021; 23(3-4):54-59. PubMed ID: 34516537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutics for the Management of Cytokine Release Syndrome in COVID-19.
    Ghosh S; Durgvanshi S; Han SS; Bhaskar R; Sinha JK
    Curr Top Med Chem; 2023; 23(2):128-142. PubMed ID: 35796445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza.
    Pacheco-Hernández LM; Ramírez-Noyola JA; Gómez-García IA; Ignacio-Cortés S; Zúñiga J; Choreño-Parra JA
    J Interferon Cytokine Res; 2022 Aug; 42(8):369-392. PubMed ID: 35674675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Before the "cytokine storm": Boosting efferocytosis as an effective strategy against SARS-CoV-2 infection and associated complications.
    Dutta S; Mukherjee A; Nongthomba U
    Cytokine Growth Factor Rev; 2022 Feb; 63():108-118. PubMed ID: 35039221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
    Front Immunol; 2022; 13():832394. PubMed ID: 35464491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
    Verma A; Adhikary A; Woloschak G; Dwarakanath BS; Papineni RVL
    Int J Radiat Biol; 2020 Nov; 96(11):1323-1328. PubMed ID: 32910699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab as a Treatment for 'Cytokine Storm Syndrome' in COVID-19: A Case Report.
    Syam AF; Pitoyo CW; Suhendro S; Zulkarnain B; Indrasari ND; Aditianingsih D; Irawan C; Susilo A; Rumende CM; Wijaya IP; Ibrahim F; Rasmin M; Alwi I; Makmun D
    Acta Med Indones; 2021 Apr; 53(2):194-201. PubMed ID: 34251348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: Inflammatory Profile.
    Wang Y; Perlman S
    Annu Rev Med; 2022 Jan; 73():65-80. PubMed ID: 34437814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and cancer: start the resolution!
    Barksdale C; Kipper FC; Tripathy S; Subbian S; Serhan CN; Panigrahy D
    Cancer Metastasis Rev; 2022 Mar; 41(1):1-15. PubMed ID: 35190921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
    Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.